Ringbeck Benedikt, Bury Daniel, Hayen Heiko, Weiss Tobias, Brüning Thomas, Koch Holger M
Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany.
Institute of Inorganic and Analytical Chemistry, University of Münster, Corrensstraße 30, Münster 48149, Germany.
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jul 1;1177:122794. doi: 10.1016/j.jchromb.2021.122794. Epub 2021 May 25.
Nonylphenol (NP) is an endocrine disrupting and ecotoxic substance that has been detected in a variety of environmental matrices. It is utilized for the production of non-ionic nonylphenol ethoxylate (NPEO) detergents and other high production volume chemicals. Human biomonitoring data are scarce and mostly limited to the non-oxidized NP, which is ubiquitous in the (laboratory) environment and susceptible to external contamination. Here, we describe a sensitive, precise, accurate and rugged analytical method for the determination of OH-NP and oxo-NP, two potential alkyl-chain-oxidized metabolites of NP in human urine. We used single isomer standards, obtained by custom synthesis, for the quantification of the sum of the respective isomers. After enzymatic hydrolysis of potential urinary phase II conjugates, urine samples were analyzed by online turbulent flow chromatography for analyte enrichment and matrix depletion coupled to reversed phase liquid chromatography with negative electrospray-ionization triple quadrupole tandem mass spectrometry detection (online-SPE-LC-MS/MS). Quantification was performed by stable isotope dilution analysis. Limits of quantification in urinary matrix were 0.5 µg/L for OH-NP and 0.25 µg/L for oxo-NP. Mean relative recoveries were 101-105% (OH-NP) and 112-117% (oxo-NP) and the method imprecision (CV) in matrix was below 5%. In spite of extensive use restrictions in the EU since 2003, we could quantify OH-NP and oxo-NP in 94% and 47% of spot urine samples from the general German population (n = 32) collected in 2014. Thus, both metabolites seem suitable as sensitive and specific urinary biomarkers of NP exposure for future human biomonitoring population studies. Currently this method is used to quantitatively investigate human NP metabolism and to derive urinary metabolite excretion fractions that can be used to calculate external doses based on urinary biomarker concentrations.
壬基酚(NP)是一种内分泌干扰物和生态毒性物质,已在多种环境基质中被检测到。它被用于生产非离子壬基酚乙氧基化物(NPEO)洗涤剂和其他大量生产的化学品。人体生物监测数据稀缺,且大多限于非氧化型NP,其在(实验室)环境中普遍存在且易受外部污染。在此,我们描述了一种灵敏、精确、准确且耐用的分析方法,用于测定人体尿液中NP的两种潜在烷基链氧化代谢物OH-NP和氧代-NP。我们使用通过定制合成获得的单异构体标准品来定量各自异构体的总和。在对潜在的尿中II相缀合物进行酶促水解后,通过在线湍流色谱法对尿液样品进行分析,以实现分析物富集和基质去除,并与具有负电喷雾电离三重四极杆串联质谱检测的反相液相色谱联用(在线固相萃取-液相色谱-串联质谱法)。通过稳定同位素稀释分析进行定量。尿液基质中的定量限对于OH-NP为0.5μg/L,对于氧代-NP为0.25μg/L。平均相对回收率为101 - 105%(OH-NP)和112 - 117%(氧代-NP),基质中的方法不精密度(CV)低于5%。尽管自2003年以来欧盟对其使用有广泛限制,但我们能够对2014年收集的德国普通人群(n = 32)的94%的随机尿样中的OH-NP和47%的氧代-NP进行定量。因此,这两种代谢物似乎都适合作为未来人体生物监测人群研究中NP暴露的灵敏且特异的尿生物标志物。目前,该方法用于定量研究人体NP代谢,并得出尿代谢物排泄分数,可用于根据尿生物标志物浓度计算外部剂量。